Prime Discoveries Biotechnology
4 known investors
Find your way into Prime Discoveries Biotechnology
Sign up to find every way you can get introduced to Prime Discoveries Biotechnology
- Your email: who you already know at Prime Discoveries Biotechnology, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Prime Discoveries Biotechnology team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.
Investors · 4
Frequently asked questions
- What does Prime Discoveries Biotechnology do?
- Prime Discoveries develops multiplex PCR diagnostic panels that detect pathogens and antimicrobial-resistance genes across areas such as respiratory infection, sepsis, gastrointestinal illness, STIs, tropical fevers, and biosurveillance. Its panels serve clinical diagnostics, hospital infection control, public-health surveillance, pharmaceutical QC, and biodefense applications.
- Who are Prime Discoveries Biotechnology's investors?
- Prime Discoveries Biotechnology's investors include Beresford Ventures, Broad Street Angels, Jude Gomila, NYU Innovation Venture Fund.


